
In the biopharmaceutical development lifecycle, the physical stability of a protein is a critical factor determining the success or failure of a drug. During production, purification, formulation development, and long-term storage, protein molecules are highly susceptible to environmental stresses (such as temperature fluctuations, pH variations, and agitation). These stresses can lead to unfolding, denaturation, or irreversible aggregation. Protein aggregation not only significantly reduces drug efficacy but can also trigger severe immunogenic responses, posing a threat to patient safety.
Creative Diagnostics is dedicated to providing comprehensive and rigorous protein stability, solubility, and aggregation state evaluation services. Utilizing cutting-edge biophysical characterization technologies, we help you identify and mitigate potential risks early in formulation development and storage. This ensures your protein molecules maintain exceptional structural and functional integrity under various demanding conditions.
To comprehensively track the behavior of proteins in solution, we have established an orthogonal matrix of characterization technologies. Through multidimensional cross-validation, we provide the most reliable profile of your molecule's state:
Our core advantage lies in providing a seamless characterization platform that bridges the gap between early developability discovery and late-stage Quality Control (QC). Utilizing advanced micro-volume detection technologies, we require only microliters of scarce samples to conduct tests directly in their native, label-free formulation environments. By employing orthogonal strategies—integrating multiple foundational technologies like light scattering and thermodynamic analysis for rigorous cross-validation—we effectively eliminate the blind spots inherent in single detection methods. This approach guarantees highly robust, compliant data that truly reflects the clinical performance potential of your drug.
We dive deep into your project background, clarify protein characteristics, and identify current challenges (e.g., high precipitation risk, high viscosity at elevated concentrations) to tailor a custom characterization plan.
We screen for the optimal column systems, mobile phases, and instrumental parameters for your specific molecule, ensuring high reproducibility and signal-to-noise ratios.
In strict accordance with SOPs, we synchronously execute SEC-MALS, DLS, and thermodynamic stability tests across multiple precision instruments to capture a panoramic data set.
We deliver a detailed scientific report featuring absolute molecular weight distribution charts, thermal stability curves, quantitative tables of aggregate proportions, and expert formulation optimization recommendations.
In the fiercely competitive biopharmaceutical arena, gaining early insights into and resolving protein stability issues is critical for ensuring smooth project advancement and mitigating costly late-stage risks. We look forward to becoming your reliable R&D partner—using data to drive decisions and safeguarding your innovative molecules. Contact our technical experts today to initiate your customized project assessment, and let's work together to accelerate the successful launch of your next-generation biologics!